Effects of clinical breakpoint changes in CLSI guidelines 2010/2011 and EUCAST guidelines 2011 on antibiotic susceptibility test reporting of Gram-negative bacilli

Expert Systems in Clinical Microbiology

(2011) T. Winstanley et al.   CLINICAL MICROBIOLOGY REVIEWS

Correlation between antibiotic consumption and resistance of Gram-negative bacteria causing healthcare-associated infections at a university hospital in Taiwan from 2000 to 2009

(2011) C.-C. Lai et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Impact of antimicrobial stewardship in critical care: a systematic review

(2011) R. Kaki et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and CLSI screening parameters for the detection of extended-spectrum  -lactamase production in clinical Enterobacteriaceae isolates

(2011) S. Polsfuss et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Susceptibility of Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae According to the New CLSI Breakpoints

(2011) Peng Wang et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Critical Assessment of Issues Applicable to Development of Antimicrobial Susceptibility Testing Breakpoints

(2011) S. G. Jenkins et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Multidrug Resistance among Gram-Negative Pathogens That Caused Healthcare-Associated Infections Reported to the National Healthcare Safety Network, 2006–2008

(2010) Alexander J. Kallen et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Role of Antimicrobial Selective Pressure and Secondary Factors on Antimicrobial Resistance Prevalence inEscherichia colifrom Food-Producing Animals in Japan

(2010) Kazuki Harada et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

Relationship of Carbapenem Restriction in 22 University Teaching Hospitals to Carbapenem Use and Carbapenem-Resistant Pseudomonas aeruginosa

(2009) A. L. Pakyz et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The changing epidemiology of resistance

(2009) P. M. Hawkey et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

The new treatment paradigm and the role of carbapenems

(2008) Robert G. Masterton   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS